← Motilal Oswal Mutual Fund

Motilal Oswal BSE Healthcare ETF

Index/ETF Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
126
Jun 2026
Equity Holdings
₹41.81 Cr
Equity only, excl. debt & cash
Top 5 Weight
34.6%
Moderate
Top 10 Weight
53.5%
Moderate
Changes
97
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
75.6% of portfolio
📋 What Happened This Month Among existing holdings, Max Healthcare Institute Limited saw the biggest increase — now at 5.35% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 5.36%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 75.6%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 76.0% 76.2% +0.2%
Healthcare Services 23.4% 23.3% -0.1%
Healthcare Equipment & Supplies 0.5% 0.5% -0.1%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 76.2% 75.6% -0.6%
Healthcare Services 23.3% 23.7% +0.4%
Healthcare Equipment & Supplies 0.5% 0.5% +0.1%
Biggest Add
Max Healthcare Institute Limited
+0.51% · now 5.35%
Biggest Trim
Divi's Laboratories Limited
-0.40% · now 5.36%

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
↑ 51 Increased ↓ 46 Decreased
#StockSectorMay 2026Jun 2026Change
1
Max Healthcare Institute Limited
₹2.24 Cr
Healthcare Services 4.84% 5.35% +0.51%
2
Anthem Biosciences Limited
₹28.98 L
Pharmaceuticals & Biotechnology 0.32% 0.69% +0.37%
3
Onesource Specialty Pharma Limited
₹34.50 L
Pharmaceuticals & Biotechnology 0.68% 0.82% +0.14%
4
Laurus Labs Limited
₹1.56 Cr
Pharmaceuticals & Biotechnology 3.59% 3.72% +0.13%
5
Rubicon Research Limited
₹11.77 L
Pharmaceuticals & Biotechnology 0.17% 0.28% +0.11%
6
Aurobindo Pharma Limited
₹1.18 Cr
Pharmaceuticals & Biotechnology 2.71% 2.81% +0.10%
7
Ajanta Pharma Limited
₹38.95 L
Pharmaceuticals & Biotechnology 0.84% 0.93% +0.09%
8
IPCA Laboratories Limited
₹63.66 L
Pharmaceuticals & Biotechnology 1.43% 1.52% +0.09%
9
Acutaas Chemicals Ltd
₹48.76 L
Pharmaceuticals & Biotechnology 1.10% 1.16% +0.06%
10
Caplin Point Laboratories Limited
₹13.91 L
Pharmaceuticals & Biotechnology 0.27% 0.33% +0.06%
#StockSectorMay 2026Jun 2026Change
1
Divi's Laboratories Limited
₹2.25 Cr
Pharmaceuticals & Biotechnology 5.76% 5.36% -0.40%
2
Sun Pharmaceutical Industries Limited
₹5.39 Cr
Pharmaceuticals & Biotechnology 13.20% 12.87% -0.33%
3
Biocon Limited
₹79.98 L
Pharmaceuticals & Biotechnology 2.12% 1.91% -0.21%
4
Glenmark Pharmaceuticals Limited
₹88.39 L
Pharmaceuticals & Biotechnology 2.31% 2.11% -0.20%
5
Wockhardt Limited
₹43.15 L
Pharmaceuticals & Biotechnology 1.14% 1.03% -0.11%
6
Alkem Laboratories Limited
₹87.46 L
Pharmaceuticals & Biotechnology 2.19% 2.09% -0.10%
7
Abbott India Limited
₹34.85 L
Pharmaceuticals & Biotechnology 0.93% 0.83% -0.10%
8
Dr. Reddy's Laboratories Limited
₹2.22 Cr
Pharmaceuticals & Biotechnology 5.39% 5.29% -0.10%
9
Fortis Healthcare Limited
₹1.34 Cr
Healthcare Services 3.29% 3.19% -0.10%
10
Natco Pharma Limited
₹22.82 L
Pharmaceuticals & Biotechnology 0.62% 0.54% -0.08%

What Stocks Does This Fund Hold?

126 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹5.39 Cr
Pharmaceuticals & Biotechnology
12.87%
2
₹2.38 Cr
Healthcare Services
5.68%
3
₹2.25 Cr
Pharmaceuticals & Biotechnology
5.36%
4
₹2.24 Cr
Healthcare Services
5.35%
5
₹2.22 Cr
Pharmaceuticals & Biotechnology
5.30%
6
₹2.22 Cr
Pharmaceuticals & Biotechnology
5.29%
7
₹1.57 Cr
Pharmaceuticals & Biotechnology
3.75%
8
₹1.56 Cr
Pharmaceuticals & Biotechnology
3.72%
9
₹1.34 Cr
Healthcare Services
3.19%
10
₹1.26 Cr
Pharmaceuticals & Biotechnology
3.00%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Motilal Oswal Mutual Fund — Portfolio & Holdings
See all funds managed by Motilal Oswal Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.